Aksys Projects $400 Mil. In PHD Hemodialysis System Revenues By 2006
This article was originally published in The Gray Sheet
Executive Summary
Aksys expects PHD personal hemodialysis system revenues in the U.S. to reach approximately $400 mil. by 2006.
You may also be interested in...
Aksys’ PHD
Personal hemodialysis system gains 510(k) clearance for home use. Initial launch efforts for the firm's first product will focus on the northwest and midwest U.S., with shipments commencing in the third quarter. Aksys has projected it will achieve a roughly 5% share of a 375,000-patient U.S. dialysis patient market with the automated system within five years (1"The Gray Sheet" Feb. 5, 2001, p. 11)...
Aksys’ PHD
Personal hemodialysis system gains 510(k) clearance for home use. Initial launch efforts for the firm's first product will focus on the northwest and midwest U.S., with shipments commencing in the third quarter. Aksys has projected it will achieve a roughly 5% share of a 375,000-patient U.S. dialysis patient market with the automated system within five years (1"The Gray Sheet" Feb. 5, 2001, p. 11)...
Baxter Expects To Roughly Double Renal Business By 2005 To $3.5 Bil.
Baxter says it plans to approximately double the size of its renal business to $3.5 bil. annually by 2005, from $1.8 bil. in 2000, increasing the unit's annual growth rate to about 15% over the next several years from the current 9% level, the firm says.